99.60
price up icon1.13%   1.11
after-market アフターアワーズ: 99.78 0.18 +0.18%
loading
前日終値:
$98.49
開ける:
$98.41
24時間の取引高:
6.96M
Relative Volume:
0.74
時価総額:
$172.35B
収益:
$46.59B
当期純損益:
$5.41B
株価収益率:
32.19
EPS:
3.0938
ネットキャッシュフロー:
$7.38B
1週間 パフォーマンス:
+2.15%
1か月 パフォーマンス:
-5.35%
6か月 パフォーマンス:
-3.04%
1年 パフォーマンス:
-25.29%
1日の値動き範囲:
Value
$98.20
$100.36
1週間の範囲:
Value
$97.20
$100.95
52週間の値動き範囲:
Value
$81.97
$134.50

Abbott Laboratories Stock (ABT) Company Profile

Name
名前
Abbott Laboratories
Name
セクター
Healthcare (1059)
Name
電話
(224) 667-6100
Name
住所
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Name
職員
115,000
Name
Twitter
@AbbottNews
Name
次回の収益日
2026-10-21
Name
最新のSEC提出書
Name
ABT's Discussions on Twitter

Compare ABT vs MDT, SYK, BSX, EW

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
ABT icon
ABT
Abbott Laboratories
99.60 168.71B 46.59B 5.41B 7.38B 3.0938
MDT icon
MDT
Medtronic Plc
88.48 110.49B 36.36B 4.84B 5.43B 3.7261
SYK icon
SYK
Stryker Corp
277.33 105.65B 25.27B 3.34B 4.57B 8.6334
BSX icon
BSX
Boston Scientific Corp
42.73 63.65B 20.62B 3.56B 3.48B 2.3847
EW icon
EW
Edwards Lifesciences Corp
85.21 49.74B 6.30B 1.07B 1.09B 1.8406

Abbott Laboratories Stock (ABT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-04-22 ダウングレード Daiwa Securities Outperform → Neutral
2025-10-10 開始されました The Benchmark Company Buy
2025-07-18 アップグレード Jefferies Hold → Buy
2025-06-16 開始されました Leerink Partners Market Perform
2024-10-08 開始されました Oppenheimer Outperform
2024-09-19 開始されました Piper Sandler Overweight
2024-07-30 ダウングレード Edward Jones Buy → Hold
2024-05-30 開始されました Goldman Buy
2023-07-21 アップグレード Wolfe Research Underperform → Peer Perform
2023-05-30 ダウングレード Morgan Stanley Overweight → Equal-Weight
2023-04-20 繰り返されました Barclays Overweight
2023-04-20 繰り返されました Bernstein Outperform
2023-04-20 繰り返されました JP Morgan Overweight
2023-04-20 繰り返されました Raymond James Outperform
2023-04-20 繰り返されました UBS Buy
2023-04-20 繰り返されました Wolfe Research Underperform
2023-03-29 開始されました UBS Buy
2022-10-26 開始されました Mizuho Neutral
2022-10-18 開始されました Barclays Overweight
2022-10-12 開始されました Jefferies Hold
2022-07-06 開始されました Wolfe Research Underperform
2022-03-02 再開されました BofA Securities Buy
2022-01-27 繰り返されました Credit Suisse Outperform
2022-01-27 繰り返されました Morgan Stanley Overweight
2022-01-27 繰り返されました Raymond James Outperform
2022-01-27 繰り返されました UBS Buy
2021-12-10 開始されました RBC Capital Mkts Outperform
2021-10-27 アップグレード Atlantic Equities Neutral → Overweight
2021-10-14 開始されました Redburn Neutral
2021-05-25 開始されました Barclays Overweight
2021-04-15 開始されました Atlantic Equities Neutral
2021-01-28 アップグレード BTIG Research Neutral → Buy
2020-09-11 開始されました Wolfe Research Outperform
2020-06-01 ダウングレード Goldman Neutral → Sell
2020-03-05 開始されました Citigroup Buy
2020-02-13 開始されました Goldman Neutral
2020-02-06 再開されました BTIG Research Neutral
2020-01-02 ダウングレード Guggenheim Buy → Neutral
2019-06-13 繰り返されました BofA/Merrill Buy
2019-02-07 繰り返されました BofA/Merrill Buy
2019-01-02 ダウングレード Citigroup Neutral → Sell
2018-11-30 アップグレード Goldman Neutral → Buy
2018-10-16 開始されました Barclays Overweight
2018-06-27 開始されました Bernstein Outperform
2018-01-30 繰り返されました Citigroup Neutral
2018-01-25 繰り返されました Stifel Buy
2018-01-25 アップグレード William Blair Mkt Perform → Outperform
2018-01-03 開始されました Evercore ISI Outperform
2018-01-02 アップグレード JP Morgan Neutral → Overweight
2018-01-02 アップグレード Morgan Stanley Equal-Weight → Overweight
2017-10-19 繰り返されました RBC Capital Mkts Outperform
2017-10-19 繰り返されました Stifel Buy
すべてを表示

Abbott Laboratories (ABT) 最新ニュース

pulisher
Oct 01, 2026

Abbott settled a government infant formula lawsuit for nearly $385 million. - Claim Depot

Oct 01, 2026
pulisher
Oct 01, 2026

Abbott Laboratories vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool

Oct 01, 2026
pulisher
Oct 01, 2026

Global Liver Cancer Diagnostics Market to Observe Impressive Growth at a CAGR of ~9% by 2034 | DelveInsight - GlobeNewswire Inc.

Oct 01, 2026
pulisher
Oct 01, 2026

In 1935, An Illinois Secretary Bought 3 Shares Of Her Company's Stock For $180. She Never Sold A Single Share And Always Reinvested Dividends. By The Time She Died In 2010 Her 3 Abbott Shares Had Turned Into $7.2 Million. - 247wallst.com

Oct 01, 2026
pulisher
Oct 01, 2026

Abbott Laboratories’ Quarterly Earnings Preview: What You Need to Know - Barchart.com

Oct 01, 2026
pulisher
Oct 01, 2026

Abbott rolls out SimpleScreen CRC blood test across the US - Medical Device Network

Oct 01, 2026
pulisher
Oct 01, 2026

Abbott launches SimpleScreen CRC for Abbott Laboratories stock - AD HOC NEWS

Oct 01, 2026
pulisher
Oct 01, 2026

Abbott Laboratories stock pre-market at EUR 87.30: plus 0.29 percent - AD HOC NEWS

Oct 01, 2026
pulisher
Sep 30, 2026

DOJ Announces $385 Million Settlement to Resolve False Claims Allegations over Abbott Laboratories Baby Formula - MedLearn Publishing

Sep 30, 2026
pulisher
Sep 30, 2026

CG Abbott plant included in $385M federal settlement - PinalCentral.com

Sep 30, 2026
pulisher
Sep 30, 2026

Abbott (ABT) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance

Sep 30, 2026
pulisher
Sep 30, 2026

Abbott (ABT) Stock May Be 25% Stretched After Biosensor Market Forecast - Simply Wall Street

Sep 30, 2026
pulisher
Sep 30, 2026

Abbott Laboratories stock underperforms Wednesday when compared to competitors - MarketWatch

Sep 30, 2026
pulisher
Sep 30, 2026

Abbott Labs launches blood test to screen for colorectal cancer - Kenosha News

Sep 30, 2026
pulisher
Sep 30, 2026

Mississippi receives $771K in Abbott formula settlement - wjtv.com

Sep 30, 2026
pulisher
Sep 30, 2026

AG Fitch Announces False Claims Settlement with Abbott Laboratories - MageeNews.com

Sep 30, 2026
pulisher
Sep 30, 2026

Mississippi to receive more than $771K in $384 million Abbott Laboratories settlement - Darkhorse Press

Sep 30, 2026
pulisher
Sep 30, 2026

Abbott Laboratories (ABT) Launches SimpleScreen CRC As Fair Value Stays In Focus - Yahoo! Finance Canada

Sep 30, 2026
pulisher
Sep 30, 2026

Mississippi to Receive $771K in $384M False Claims Settlement with Abbott Laboratories - tippahnews.com

Sep 30, 2026
pulisher
Sep 30, 2026

Abbott Launches Simplescreen Crc Blood Test in the U.S - marketscreener.com

Sep 30, 2026
pulisher
Sep 30, 2026

Abbott launches Freenome’s colorectal cancer screening test - MedTech Dive

Sep 30, 2026
pulisher
Sep 30, 2026

In 1935, Grace Groner, a secretary, invested $180 in her employer Abbott; 75 years later, it had grown to - The Economic Times

Sep 30, 2026
pulisher
Sep 29, 2026

Abbott Laboratories (NYSE:ABT): Are Investors Getting Over Their Scepticism Over The Company's Bold US$21bn Bet On Exact Sciences? - Stocks Down Under

Sep 29, 2026
pulisher
Sep 29, 2026

Form 4 Abbott Laboratories For: 29 September By Investing.com - Investing.com UK

Sep 29, 2026
pulisher
Sep 28, 2026

Abbott Laboratories stock at USD 100.95 on September 28, 2026 - AD HOC NEWS

Sep 28, 2026
pulisher
Sep 28, 2026

Abbott lawsuit alleges spinal cord stimulators can fail, worsen nerve damage - Top Class Actions

Sep 28, 2026
pulisher
Sep 28, 2026

Global Therapeutic Drug Monitoring Consumables Market Forecast, 2026-2032 - GlobeNewswire Inc.

Sep 28, 2026
pulisher
Sep 27, 2026

Gilead vs. Abbott: Which Dividend Healthcare Stock Offers the Better Risk-Reward? - Yahoo Finance

Sep 27, 2026
pulisher
Sep 27, 2026

Abbott Laboratories Lobbying Profile, 2003 - OpenSecrets

Sep 27, 2026
pulisher
Sep 26, 2026

3 Dividend Stocks To Watch As High Rates Test Defensive Shares - Simply Wall Street

Sep 26, 2026
pulisher
Sep 25, 2026

Form 4 Abbott Laboratories For: 25 September By Investing.com - Investing.com India

Sep 25, 2026
pulisher
Sep 25, 2026

At $103.99 a share, an Abbott Laboratories (ABT) director delivered or withheld shares for exercise costs or taxes. - Stock Titan

Sep 25, 2026
pulisher
Sep 25, 2026

Abbott Laboratories stock falls 2.32 percent below yearly high effects? no - AD HOC NEWS

Sep 25, 2026
pulisher
Sep 25, 2026

Is Abbott Laboratories (NYSE:ABT) Facing a Real Market Test? - Kalkine Media

Sep 25, 2026
pulisher
Sep 25, 2026

Abbott Laboratories stock loses 1.82 percent before the bell - ad-hoc-news.de

Sep 25, 2026
pulisher
Sep 24, 2026

How Lingo Partnership Will Impact Abbott Stock (ABT) - Simply Wall Street

Sep 24, 2026
pulisher
Sep 24, 2026

Abbott to pay nearly $385 million to settle infant formula allegations - ConsumerAffairs

Sep 24, 2026
pulisher
Sep 24, 2026

Abbott Laboratories (ABT) is Facing Segment Competition and Sluggish Nutrition Recovery - Yahoo Finance

Sep 24, 2026
pulisher
Sep 24, 2026

Abbott Laboratories stock reports Q2 growth and earnings beat - AD HOC NEWS

Sep 24, 2026
pulisher
Sep 24, 2026

Abbott Laboratories stock rises 0.69 percent ahead of the open - AD HOC NEWS

Sep 24, 2026
pulisher
Sep 23, 2026

Abbott partners with Berry Street to add nutrition coaching to Lingo - Drug Delivery Business

Sep 23, 2026
pulisher
Sep 23, 2026

Abbott Laboratories stock ends the day 0.69 percent higher at USD 103.69 - AD HOC NEWS

Sep 23, 2026
pulisher
Sep 23, 2026

Abbott Laboratories: A Strong Business At A Fair Price (NYSE:ABT) - Seeking Alpha

Sep 23, 2026
pulisher
Sep 23, 2026

Sinocare Asks Court To Rule Device Won't Infringe Abbott IP - Law360

Sep 23, 2026
pulisher
Sep 23, 2026

What Makes Abbott Laboratories (ABT) an Attractive Opportunity? - Yahoo Finance

Sep 23, 2026
pulisher
Sep 23, 2026

Abbott and Berry Street team up on personalized nutrition tracking - marketscreener.com

Sep 23, 2026
pulisher
Sep 23, 2026

Is Abbott Laboratories (ABT) Still Undervalued On Volt’s First US And Canada Procedures? - Simply Wall Street

Sep 23, 2026
pulisher
Sep 23, 2026

Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

Sep 23, 2026
pulisher
Sep 23, 2026

Abbott and Berry Street partner to combine gluc... - Pluang

Sep 23, 2026
pulisher
Sep 23, 2026

A 15% discount on Abbott's four-week glucose-monitor plans will go to Berry Street users. - Stock Titan

Sep 23, 2026
pulisher
Sep 23, 2026

Abbott Laboratories stock gains 1.12 percent as settlement weighs - AD HOC NEWS

Sep 23, 2026

Abbott Laboratories (ABT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
MDT MDT
$88.48
price up icon 0.83%
SYK SYK
$277.33
price up icon 0.13%
BSX BSX
$42.73
price up icon 1.64%
EW EW
$85.21
price up icon 1.15%
$84.11
price down icon 0.36%
大文字化:     |  ボリューム (24 時間):